methylprednisolone acetate has been researched along with Lupus Erythematosus, Systemic in 1 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
HARNECKER, J | 1 |
JALIL, J | 1 |
1 other study available for methylprednisolone acetate and Lupus Erythematosus, Systemic
Article | Year |
---|---|
[A PROLONGED-ACTION CORTICOSTEROID. DEPO-MEDROL IN THE TREATMENT OF 25 CASES OF LUPUS ERYTHEMATOSUS DISSEMINATUS].
Topics: Adrenal Cortex Hormones; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Methylprednisolo | 1964 |